TAVR后再干预的预测因素与结局:FRANCE 2与FRANCE TAVI注册研究
该研究基于FRANCE 2和FRANCE TAVI注册研究,纳入2010至2022年接受TAVR的72,850例患者,评估再干预(外科取出TAVR或再次TAVR)的发生率、预测因素及长期结局。结果显示8年总体再干预累积发生率为1.7%,其中62.1%为早期再干预,再干预后6年死亡率高但早期与晚期再干预者相似。
要点
- 8年再干预累积发生率为1.7%,以再次TAVR为主。
- 再干预多发生于术后早期(62.1%)。
- 术后即刻平均主动脉瓣压差>20 mm Hg者再干预更频繁。
核心结论
- TAVR后再干预仍罕见,且大多在术后早期进行,方式以再次TAVR为主。
研究设计与样本
- 基于FRANCE 2和FRANCE TAVI注册研究,纳入2010至2022年间接受TAVR的患者共72,850例,排除因感染性心内膜炎行再干预者。
主要发现
- 8年总体再干预累积发生率为1.7%,包括591例再次TAVR和111例需取出TAVR,Bentall干预发生率低。
- 再干预在62.1%的病例中发生于早期,且即刻TAVR后平均主动脉瓣压差>20 mm Hg的患者再干预更频繁。
- 年龄、TAVR前平均主动脉瓣压差以及TAVR后平均主动脉瓣压差>20 mm Hg、主动脉瓣反流≥2级和TAVR后经皮冠状动脉介入治疗可预测再干预。
- 6年死亡率高,但早期与晚期再干预患者相似(76.2% vs 64.0%;P=0.77)。
临床怎么用
- TAVR术后应关注即刻平均主动脉瓣压差>20 mm Hg、主动脉瓣反流≥2级及术后经皮冠状动脉介入治疗等预测因素。
- 再干预多发生于术后早期,术后第一年需密切随访。
局限性
- 需进一步研究,尤其是针对预期寿命更长的年轻患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In a context of extending transcatheter aortic valve replacement (TAVR) to patients with a longer life expectancy, it is important to better document the incidence and outcomes of reintervention. OBJECTIVES: The authors sought to evaluate the incidence, predictive factors, and long-term outcomes of surgical (explant TAVR) or transcatheter (redo TAVR) reintervention after TAVR. METHODS: Patients who had a TAVR between 2010 and 2022 recorded in the FRANCE 2 and FRANCE TAVI registries were included in the analysis. Cumulative incidence of early (≤1 year) and late (>1 year) reintervention was assessed using the Kalbfleisch and Prentice method to account for all-cause death as a competing risk. Patients who had reintervention for infective endocarditis were excluded. Long-term mortality was evaluated using Kaplan-Meier analysis. RESULTS: Among 72,850 patients included, the cumulative incidence of overall reintervention at 8 years was 1.7% including 591 patients who had redo TAVR and 111 patients who required explant TAVR with a low incidence of Bentall intervention. Reintervention occurred mostly early in 62.1% of cases and was more frequent in patients who had a mean aortic gradient >20 mm Hg immediately after index TAVR. Age and mean aortic gradient before TAVR and mean aortic gradient >20 mm Hg, aortic regurgitation ≥ grade 2, and percutaneous coronary intervention after TAVR were predictive of reintervention. Six-year mortality was high but was similar in patients who had early and late reintervention (76.2% vs 64.0%; P = 0.77). CONCLUSIONS: Reintervention after TAVR remains rare and was mostly performed early after the procedure and by redo TAVR. Further studies are warranted, particularly in younger patients with longer life expectancy.
引用
- Durand E, Eltchaninoff H, Tchetche D, et al. Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement: FRANCE 2 and FRANCE TAVI Registries. J Am Coll Cardiol. 2025. PMID: 40044295. doi:10.1016/j.jacc.2024.11.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。